These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 19934663)
61. Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents. Gupta V; Harkin DP; Kawakubo H; Maheswaran S Curr Cancer Drug Targets; 2004 Mar; 4(2):165-82. PubMed ID: 15032667 [TBL] [Abstract][Full Text] [Related]
62. Signaling crosstalk underlying synergistic induction of astrocyte differentiation by BMPs and IL-6 family of cytokines. Yanagisawa M; Nakashima K; Takizawa T; Ochiai W; Arakawa H; Taga T FEBS Lett; 2001 Feb; 489(2-3):139-43. PubMed ID: 11165238 [TBL] [Abstract][Full Text] [Related]
63. GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Levine AJ; Brivanlou AH Development; 2006 Jan; 133(2):209-16. PubMed ID: 16339188 [TBL] [Abstract][Full Text] [Related]
64. The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers. Harland RM Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10243-6. PubMed ID: 7937933 [No Abstract] [Full Text] [Related]
65. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells. Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503 [TBL] [Abstract][Full Text] [Related]
66. A member of the transforming growth factor-beta receptor family from Echinococcus multilocularis is activated by human bone morphogenetic protein 2. Zavala-Góngora R; Kroner A; Bernthaler P; Knaus P; Brehm K Mol Biochem Parasitol; 2006 Apr; 146(2):265-71. PubMed ID: 16434111 [No Abstract] [Full Text] [Related]
69. [Self-renewal signaling pathway and culture system in vitro of embryonic stem cells]. Zhu J; Wang Y; Diao Y Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):188-93. PubMed ID: 17357470 [TBL] [Abstract][Full Text] [Related]
70. Transforming growth factor β1 enhances stemness of head and neck squamous cell carcinoma cells through activation of Wnt signaling. Bae WJ; Lee SH; Rho YS; Koo BS; Lim YC Oncol Lett; 2016 Dec; 12(6):5315-5320. PubMed ID: 28105240 [TBL] [Abstract][Full Text] [Related]
71. Vascular-derived TGF-β increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain. Pineda JR; Daynac M; Chicheportiche A; Cebrian-Silla A; Sii Felice K; Garcia-Verdugo JM; Boussin FD; Mouthon MA EMBO Mol Med; 2013 Apr; 5(4):548-62. PubMed ID: 23526803 [TBL] [Abstract][Full Text] [Related]
72. Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor, a Transforming Growth Factor β Rheostat That Controls Murine Treg Cell/Th17 Cell Differentiation and the Development of Autoimmune Arthritis by Reducing Interleukin-2 Signaling. Postigo J; Iglesias M; Álvarez P; Jesús Augustin J; Buelta L; Merino J; Merino R Arthritis Rheumatol; 2016 Jun; 68(6):1551-62. PubMed ID: 26714180 [TBL] [Abstract][Full Text] [Related]
74. Context-dependent action of transforming growth factor β family members on normal and cancer stem cells. Caja L; Kahata K; Moustakas A Curr Pharm Des; 2012; 18(27):4072-86. PubMed ID: 22630079 [TBL] [Abstract][Full Text] [Related]
75. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells. Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696 [TBL] [Abstract][Full Text] [Related]
76. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667 [TBL] [Abstract][Full Text] [Related]